Illumina’s Stock Plummets After Analyst Downgrade: Investors Reassess Future ProspectsIllumina’s stock price has plummeted after an analyst downgrade, sparking concerns about the company’s business model and growth prospects.Illumina Inc Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated Vanessa Liu 14/02/2025, 05:42 2 minutes to read